ArticlePharmaceutics2022

Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems.

Ahmed O Shalash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.